Companies / Alder Biopharmaceuticals Inc
Alder Biopharmaceuticals Inc
ALDRCIK 1423824
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 27, 2015 | Schatzman Randall C CEO | Sell Open-market sale | Common Stock | $1.83M | -64K -36.64% | 109,921 | medium |
| May 21, 2015 | Dow Stephen M Director | Sell Open-market sale | Common Stock | $1.31M | -20K -5.98% | 314,203 | medium |
| Jan 26, 2015 | Schatzman Randall C CEO | Sell Open-market sale | Common Stock | $1.02M | -36K -17.35% | 173,499 | medium |
| May 20, 2015 | Dow Stephen M Director | Sell Open-market sale | Common Stock | $341.8K | -8K -0.20% | 4,313,992 | medium |
| Jan 26, 2015 | Latham John A Executive | Sell Open-market sale | Common Stock | $221.0K | -8K -3.64% | 208,988 | medium |
| Jan 27, 2015 | Latham John A Executive | Sell Open-market sale | Common Stock | $205.3K | -7K -3.31% | 208,988 | medium |
| Jan 26, 2015 | Litton Mark James Executive | Sell Open-market sale | Common Stock | $145.7K | -5K -5.82% | 84,159 | medium |
| Mar 2, 2015 | Latham John A Executive | Sell Open-market sale | Common Stock | $119.3K | -5K -2.13% | 208,988 | medium |